 Myriad Genetics, Inc. NASDAQ:MYGN Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Foster Harris - IR Paul Diaz - CEO, President Director Nicole Lambert - COO Bryan Riggsbee - EVP, CFO Treasurer Conference Call Participants Kyle Boucher - Cowen and Company Jack Meehan - Nephron Research Operator Greetings, and welcome to the Myriad Genetics Second Quarter 2022 Financial Earnings Conference Call. Operator Instructions. 